Literature DB >> 8648699

Inhibitory activity of the equine infectious anemia virus major 5' splice site in the absence of Rev.

W Tan1, M Schalling, C Zhao, M Luukkonen, M Nilsson, E M Fenyö, G N Pavlakis, S Schwartz.   

Abstract

The major 5' splice site of equine infectious anemia virus (EIAV) conforms to the consensus 5' splice site in eight consecutive positions and is located immediately upstream of the gag AUG. Our results show that the presence of this 5' splice site on the EIAV gag mRNA decreases Gag production 30- to 60-fold. This is caused by inefficient nuclear mRNA export and inefficient mRNA utilization. Inhibition could be overcome by providing human immunodeficiency virus type 1 Rev/Rev-responsive element, human T-cell leukemia virus type 1 Rex/Rex-responsive element, or simian retrovirus type 1 constitutive transport element. In addition, inhibition could be abolished by introducing single point mutations in the 5' splice site or by moving the 5' splice site away from its natural position immediately upstream of the gag AUG. This demonstrates that both maintenance of a perfect consensus 5' splice site and its proper location on the mRNA are important for inhibitory activity of the EIAV major 5' splice site.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8648699      PMCID: PMC190240     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  86 in total

1.  Regulation by HIV Rev depends upon recognition of splice sites.

Authors:  D D Chang; P A Sharp
Journal:  Cell       Date:  1989-12-01       Impact factor: 41.582

Review 2.  The human immunodeficiency virus type 1 Rev protein: a pivotal protein in the viral life cycle.

Authors:  T Hope; R J Pomerantz
Journal:  Curr Top Microbiol Immunol       Date:  1995       Impact factor: 4.291

3.  The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localization.

Authors:  M Emerman; R Vazeux; K Peden
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

4.  Equine infectious anemia virus tat: insights into the structure, function, and evolution of lentivirus trans-activator proteins.

Authors:  P Dorn; L DaSilva; L Martarano; D Derse
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

5.  Cloning and characterization of cDNAs encoding equine infectious anemia virus tat and putative Rev proteins.

Authors:  R M Stephens; D Derse; N R Rice
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

6.  Analysis of regulatory elements of the equine infectious anemia virus and caprine arthritis-encephalitis virus long terminal repeats.

Authors:  L Sherman; A Yaniv; H Lichtman-Pleban; S R Tronick; A Gazit
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

7.  Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1.

Authors:  S Schwartz; B K Felber; D M Benko; E M Fenyö; G N Pavlakis
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

8.  The U5 sequence is a cis-acting repressive element for genomic RNA expression of human T cell leukemia virus type I.

Authors:  M Seiki; A Hikikoshi; M Yoshida
Journal:  Virology       Date:  1990-05       Impact factor: 3.616

9.  Efficient expression of the human papillomavirus type 16 L1 protein in epithelial cells by using Rev and the Rev-responsive element of human immunodeficiency virus or the cis-acting transactivation element of simian retrovirus type 1.

Authors:  W Tan; B K Felber; A S Zolotukhin; G N Pavlakis; S Schwartz
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

10.  A human nucleoporin-like protein that specifically interacts with HIV Rev.

Authors:  C C Fritz; M L Zapp; M R Green
Journal:  Nature       Date:  1995-08-10       Impact factor: 49.962

View more
  5 in total

1.  Specific inactivation of inhibitory sequences in the 5' end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells.

Authors:  Brian Collier; Daniel Oberg; Xiaomin Zhao; Stefan Schwartz
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  Mutational inactivation of two distinct negative RNA elements in the human papillomavirus type 16 L2 coding region induces production of high levels of L2 in human cells.

Authors:  Daniel Oberg; Brian Collier; Xiaomin Zhao; Stefan Schwartz
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

3.  mRNA instability elements in the human papillomavirus type 16 L2 coding region.

Authors:  M Sokolowski; W Tan; M Jellne; S Schwartz
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

4.  Inhibition of HPV-16 L1 expression from L1 cDNAs correlates with the presence of hnRNP A1 binding sites in the L1 coding region.

Authors:  Xiaomin Zhao; Stefan Schwartz
Journal:  Virus Genes       Date:  2007-11-27       Impact factor: 2.332

Review 5.  Sequence Determinants for Nuclear Retention and Cytoplasmic Export of mRNAs and lncRNAs.

Authors:  Alexander F Palazzo; Eliza S Lee
Journal:  Front Genet       Date:  2018-10-17       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.